523 reports of this reaction
2.6% of all LANREOTIDE ACETATE reports
#7 most reported adverse reaction
ABDOMINAL PAIN is the #7 most commonly reported adverse reaction for LANREOTIDE ACETATE, manufactured by Ipsen Biopharmaceuticals, Inc.. There are 523 FDA adverse event reports linking LANREOTIDE ACETATE to ABDOMINAL PAIN. This represents approximately 2.6% of all 20,256 adverse event reports for this drug.
Patients taking LANREOTIDE ACETATE who experience abdominal pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL PAIN is a less commonly reported adverse event for LANREOTIDE ACETATE, but still significant enough to appear in the safety profile.
In addition to abdominal pain, the following adverse reactions have been reported for LANREOTIDE ACETATE:
The following drugs have also been linked to abdominal pain in FDA adverse event reports:
ABDOMINAL PAIN has been reported as an adverse event in 523 FDA reports for LANREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL PAIN accounts for approximately 2.6% of all adverse event reports for LANREOTIDE ACETATE, making it a notable side effect.
If you experience abdominal pain while taking LANREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.